I have 28 years of experience, and specialize in the field of pharmaceutical process development with specific knowledge in the areas of scale-up, tech transfer and working with external partners. I have published on such topics as enhancing productivity of process development, modeling and simulation and pharmaceutical processing. I had the unusual opportunity to lead the process development and commercial introduction of the process to make the active ingredient in the HIV medicine Crixivan at a time when there were no other effective agents on the market – creating unusual pressures with respect to timelines, technologies, risk management and scale-up. Interactions with the HIV community were essential to ensure a proper path and gain their support.